Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC decreased its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 15.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,030 shares of the health services provider’s stock after selling 892 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Amedisys were worth $478,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Calamos Advisors LLC acquired a new stake in Amedisys during the 4th quarter valued at approximately $23,015,000. Wolverine Asset Management LLC grew its stake in Amedisys by 13.9% in the fourth quarter. Wolverine Asset Management LLC now owns 35,181 shares of the health services provider’s stock worth $3,344,000 after purchasing an additional 4,299 shares in the last quarter. SG Americas Securities LLC increased its holdings in shares of Amedisys by 181.1% in the 4th quarter. SG Americas Securities LLC now owns 63,953 shares of the health services provider’s stock valued at $6,079,000 after acquiring an additional 41,206 shares during the last quarter. Bank of Nova Scotia bought a new stake in Amedisys during the third quarter valued at $26,671,000. Finally, Hsbc Holdings PLC raised its holdings in shares of Amedisys by 184.9% during the third quarter. Hsbc Holdings PLC now owns 110,479 shares of the health services provider’s stock worth $10,327,000 after purchasing an additional 71,705 shares during the period. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Trading Up 0.0 %

Shares of AMED opened at $96.23 on Friday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.31. The stock has a market cap of $3.14 billion, a PE ratio of -150.36, a PEG ratio of 3.61 and a beta of 0.84. Amedisys, Inc. has a 1 year low of $74.61 and a 1 year high of $97.36. The stock has a 50 day simple moving average of $92.92 and a 200-day simple moving average of $93.64.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings data on Wednesday, April 24th. The health services provider reported $1.03 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.01. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The company had revenue of $571.41 million during the quarter, compared to analyst estimates of $565.38 million. During the same quarter last year, the business posted $1.00 earnings per share. The company’s revenue was up 2.7% on a year-over-year basis. On average, sell-side analysts predict that Amedisys, Inc. will post 4.56 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. StockNews.com raised shares of Amedisys from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Cantor Fitzgerald reiterated a “neutral” rating and set a $101.00 price target on shares of Amedisys in a research report on Thursday, April 25th. Royal Bank of Canada boosted their price objective on Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, March 25th. Finally, Raymond James restated a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. Seven research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $100.80.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.